Load mobile navigation

Andrew and Linda Leaver

Andrew Leaver formed Staffordshire pharmaceuticals company Clinigen in 2010. When Clinigen was floated on the AIM market for £135m in September 2012, Andrew and Linda sold shares for £37m - and they retained a £47 million stake in the group.